Becker's Healthcare January 16, 2025
Alexandra Murphy

An analysis of the Inflation Reduction Act of 2022 found that a majority of Medicare Part D enrollees will see lower total out-of-pocket costs in 2025.

The law’s new $2,000 out-of-pocket spending cap for prescription drugs is expected to save most affected enrollees an average of $2,474, representing a 48% reduction in their overall spending, including premiums and cost sharing, according to the report published by AARP.

The analysis, which incorporates...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Survey / Study, Trends
Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says
Why not tie Medicare payments to inflation?
Medicare Accountable Care Organizations In 2023: Large Savings With Increasing Value-Based Programmatic Competition
Medicare Enrollment Trends in Four Charts
Innovation At CMS: Advancing A Person-Centered Health System

Share This Article